EMA: First Adapted COVID-19 Vaccines Expected In September

Data Still Awaited On Valneva Vaccine & Molnupiravir

As work continues on vaccines adapted to tackle variants of SARS-CoV-2, the EU regulator says the decision-making on such products should take place at a global level.

Concept of safety of corona virus vaccination.
Vaccines are being adapted for variant viruses • Source: Shutterstock/ Anze Furlan

The European Medicines Agency is working with vaccine companies on the development of variant-adapted COVID-19 vaccines and says it expects the first ones to be approved by the autumn.

It is also working with industry on the development of second-generation vaccines with broader and more durable protection, but these...

More from Vaccines

More from Pink Sheet